Catalog
/
Medicine and Health Sciences
/
Pharmacology
/
BioDrugs
BioDrugs
Publisher: Springer Nature ·
ISSN 1173-8804,1179-190X ·
121 articles
☆
Antisense Oligonucleotides as Quantitative Modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): A Threshold-Based Therapeutic Framework for Class I and Class V CFTR Mutations
Martina Battistini, Laura Lagostena, Dario Balestra, Mirko Pinotti, Debora Baroni
BioDrugs
· Pharmacology
· 2026-11-13
☆
Impact of Anti-drug Antibodies in Patients with Fabry Disease under Enzyme Replacement Therapy: Long-Term Outcomes
Malte Lenders, Elisa Rudolph, Robert Radke, Peter Nordbeck, Eva Brand
BioDrugs
· Pharmacology
· 2026-11-01
☆
Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users
Laetitia Penso, Mounya Abboud, Mahmoud Zureik, Emilie Sbidian
BioDrugs
· Pharmacology
· 2026-10-30
☆
Sustained Efficacy and Safety of Mirikizumab Through 152 Weeks in Chinese Patients with Moderately to Severely Active Crohn’s Disease: A Subpopulation Analysis of the VIVID-1 and VIVID-2 Phase 3 Trials
Xiang Gao, Qian Cao, Xiaowei Liu, Baili Chen, Wenjia Liu, Wen Tang, Yufang Wang, Jie Zhong, Zhaotao Li, Xiaoyan Wang, Yi Sun, Prashant Gupta, Jiao Yu, Jiawei Xu, Minhu Chen
BioDrugs
· Pharmacology
· 2026-10-28
☆
IL-6 Blockade for Antibody-Mediated Transplant Rejection: What Does the Evidence Say?
Mehmet Kanbay, Sidar Copur, Can Altunbulakli, Zeynep B. Eren, Ibrahim Gulmaliyev, Nur I. Genc, Caner Süsal, Adrian Covic, Mahmut Altindal
BioDrugs
· Pharmacology
· 2026-10-23
☆
Incidence and Risk Factors of Treatment-Emergent Eczematous Reactions in Patients with Psoriasis Treated with Biologics: A Systematic Review and Meta-Analysis
Yifei Feng, Yan Lu
BioDrugs
· Pharmacology
· 2026-10-16
☆
From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate
Björn Capsius, Marija Pesic, Ravil Niyazov, Susanne Pippig, Michael Trieb, Rahul Hole, Sigrid Balser, Andreas Seidl
BioDrugs
· Pharmacology
· 2026-09-19
☆
Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects
Qiang Chen
BioDrugs
· Pharmacology
· 2026-09-17
☆
HLX11: A Pertuzumab Biosimilar
Aisling McGuigan
BioDrugs
· Pharmacology
· 2026-09-17
☆
Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk
Ted R. Mikuls, Tuhina Neogi, Angelo Gaffo
BioDrugs
· Pharmacology
· 2026-09-14
☆
Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases
Liyan Qiu, Jonas Torbjörn Ungerbäck, Eric Paul Bennett, Rasmus O. Bak
BioDrugs
· Pharmacology
· 2026-09-14
☆
Biosimilars: A Virtuous Cycle of Sustainability and Innovation
Fernando de Mora, Vicente Merino-Bohórquez, Rosario García-Vicuña, Isabel Río-Álvarez
BioDrugs
· Pharmacology
· 2026-09-14
☆
The Effect of Anti-drug Antibodies on the Bioavailability of Alglucosidase Alfa in Classic Infantile Pompe Disease
Martha Caterina Faraguna, Daniël A. M. Lambregts, Ina Barzel, Edwin H. Jacobs, Marianne Hoogeveen-Westerveld, Nadine A. M. E. van der Beek, W. W. M. Pim Pijnappel, Serena Gasperini, Tim Preijers, Johanna M. P. van den Hout, Ans T. van der Ploeg
BioDrugs
· Pharmacology
· 2026-09-11
☆
Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability
Lourdes Sainero-Alcolado, Dilraj Lama, Mohammad Alzrigat, Marie Arsenian-Henriksson
BioDrugs
· Pharmacology
· 2026-09-01
☆
Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial
Oh Chan Kwon, Soo Min Ahn, Seokchan Hong, Yeon Hong Seo, Min Kim, Joo Yong Lee, Un Chul Park, Seong Joon Ahn, Min-Chan Park, Eun Young Lee, Tae-Hwan Kim, Yong-Gil Kim
BioDrugs
· Pharmacology
· 2026-08-28
☆
Targeting CD38 Across Autoimmune and Plasma Cell–Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape
Dario Roccatello, Savino Sciascia, Daniela Rossi, Roberta Fenoglio
BioDrugs
· Pharmacology
· 2026-08-18
☆
Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study
Xin Ma, Yue Jiang, Dongmei Liu, Quanruo Xu, Fanlingzi Shen, Zhen Duan, Xiangjin Gao, Xiuqi Zhang, Ruiqi Cai, Rui Zhang, Bin Li, Ruiping Wang
BioDrugs
· Pharmacology
· 2026-08-03
☆
Population Pharmacokinetic Comparability of CT-P16 Versus EU-Avastin® and US-Avastin® in Healthy Subjects and Patients with Non-Squamous Non-Small Cell Lung Cancer
Taekyung Kim, Heungjo Kim, Hongjae Lee, Keumyoung Ahn, Taehong Park, Hyungseok Baek, Min Jung Chang
BioDrugs
· Pharmacology
· 2026-08-02
☆
Expanding Patient Access to Advanced Therapies
Elena Guillen, Ana Hidalgo-Simon
BioDrugs
· Pharmacology
· 2026-07-21
☆
Home Infusion With Recombinant Human α-Glucosidase in Children With Pompe Disease: The Dutch Experience Over 20 Years Across the Spectrum From Classic Infantile to Late-Onset Phenotypes
Imke A. M. Ditters, Hidde H. Huidekoper, Jacqueline F. Hardon, Michelle E. Kruijshaar, Ans T. van der Ploeg, Johanna M. P. van den Hout
BioDrugs
· Pharmacology
· 2026-07-20
☆
Why Product Drift Is Not an Issue for Biosimilars/Biologics: Start the Same, Stay the Same
Joseph P. Park, Hyunhee Oh, Gillian R. Woollett
BioDrugs
· Pharmacology
· 2026-07-08
☆
Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis
Carlos Roberto Montes-de-Oca-Saucedo, Laura Ghanem, Najwaa Kirmani, Bruno Briceño-Villardaga, Andrea Michelle Talancon-Solana, Adela Jatzari Salinas-Ocampo, Grecia Sereno-Acevedo, Adolfo Soto-Domínguez, Raquel Rivera-Díaz
BioDrugs
· Pharmacology
· 2026-07-02
☆
Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities
Rebecca J. Wilson, Charmaine A. Ramlogan-Steel, William J. Deasy, Sarah J. Greenstein, Christopher J. Layton, Jason C. Steel
BioDrugs
· Pharmacology
· 2026-06-25
☆
Review of Quality Attributes and Analytical Methods Used for Comparative Analytical Assessment of Monoclonal Antibodies as Part of Successful Biosimilar Approvals in the United States and European Union
Rakesh Aithal, Olivia M. Majedi, Diane McCarthy, Fouad Atouf, Niomi Peckham
BioDrugs
· Pharmacology
· 2026-06-17
☆
Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab
Anika M. Valk, Jolinde van Strien, Ninotska Derksen, Dorien Kos, Júlia Castellon Teixell, Jerry Janssen, Floris C. Loeff, Lisanne Dijk, Maureen Leeuw, Catherine Smith, Teresa Tsakok, Richard Warren, Nick J. Reynolds, Christopher E. M. Griffiths, Jonathan Barker, BSTOP Study Group, PSORT Consortium, Robert Rissman, Wouter ten Voorde, Justin Jacobse, Daniel Alvarez, Marieke van Ham, Gertjan Wolbink, Anja ten Brinke, Theo Rispens
BioDrugs
· Pharmacology
· 2026-06-17
☆
An Overview and Trend Analysis of Biosimilar Approvals in China
Mei Yang, Ning Zhang, Haixue Wang
BioDrugs
· Pharmacology
· 2026-06-17
☆
Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field
Matthew J. Slarve, Christine Tkaczyk, Michael P. Doyle, Timothy J. Break, Alexander B. Smith, Galit Alter, Brian Luna, Brad Spellberg, Antonio DiGiandomenico
BioDrugs
· Pharmacology
· 2026-06-15
☆
mRNA Vaccines for Influenza: Hope for a Universal Vaccine?
Priscilla Omotara, Wandi Zhu, Bao-Zhong Wang
BioDrugs
· Pharmacology
· 2026-06-15
☆
Giving Antibiotics a Second Chance: Evolutionary Trade-Offs and Phage-Driven Restoration of Antibiotic Susceptibility
Michał Wójcicki, Martyna Cieślik, Andrzej Górski, Ewa Jończyk-Matysiak
BioDrugs
· Pharmacology
· 2026-06-12
☆
Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?
Capucine Arrivé, Marie Hotot, Jean-François Jourdil, Françoise Stanke-Labesque
BioDrugs
· Pharmacology
· 2026-06-12